NM_001701.4:c.602G>A

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBP6_Very_Strong

The NM_001701.4(BAAT):​c.602G>A​(p.Arg201His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000199 in 1,584,590 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R201P) has been classified as Benign.

Frequency

Genomes: 𝑓 0.0011 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00011 ( 1 hom. )

Consequence

BAAT
NM_001701.4 missense

Scores

3
15

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -1.25

Publications

16 publications found
Variant links:
Genes affected
BAAT (HGNC:932): (bile acid-CoA:amino acid N-acyltransferase) The protein encoded by this gene is a liver enzyme that catalyzes the transfer of C24 bile acids from the acyl-CoA thioester to either glycine or taurine, the second step in the formation of bile acid-amino acid conjugates. The bile acid conjugates then act as a detergent in the gastrointestinal tract, which enhances lipid and fat-soluble vitamin absorption. Defects in this gene are a cause of familial hypercholanemia (FHCA). Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2008]
BAAT Gene-Disease associations (from GenCC):
  • hypercholanemia, familial 1
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • bile acid CoA:amino acid N-acyltransferase deficiency
    Inheritance: AR Classification: MODERATE Submitted by: ClinGen
  • familial hypercholanemia
    Inheritance: AR, Unknown Classification: SUPPORTIVE, LIMITED Submitted by: Orphanet, Laboratory for Molecular Medicine
  • bile acid conjugation defect 1
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0037721395).
BP6
Variant 9-101368187-C-T is Benign according to our data. Variant chr9-101368187-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 288463.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
BAATNM_001701.4 linkc.602G>A p.Arg201His missense_variant Exon 3 of 4 ENST00000259407.7 NP_001692.1 Q14032
BAATNM_001127610.2 linkc.602G>A p.Arg201His missense_variant Exon 3 of 4 NP_001121082.1 Q14032
BAATNM_001374715.1 linkc.602G>A p.Arg201His missense_variant Exon 3 of 4 NP_001361644.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
BAATENST00000259407.7 linkc.602G>A p.Arg201His missense_variant Exon 3 of 4 1 NM_001701.4 ENSP00000259407.2 Q14032

Frequencies

GnomAD3 genomes
AF:
0.00106
AC:
160
AN:
151042
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00384
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000959
GnomAD2 exomes
AF:
0.000259
AC:
65
AN:
251358
AF XY:
0.000221
show subpopulations
Gnomad AFR exome
AF:
0.00363
Gnomad AMR exome
AF:
0.000116
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000176
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000108
AC:
155
AN:
1433412
Hom.:
1
Cov.:
33
AF XY:
0.0000883
AC XY:
63
AN XY:
713770
show subpopulations
African (AFR)
AF:
0.00396
AC:
129
AN:
32570
American (AMR)
AF:
0.000159
AC:
7
AN:
43914
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24526
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36440
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86054
European-Finnish (FIN)
AF:
0.0000198
AC:
1
AN:
50552
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5558
European-Non Finnish (NFE)
AF:
0.00000456
AC:
5
AN:
1095594
Other (OTH)
AF:
0.000223
AC:
13
AN:
58204
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
10
20
29
39
49
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00106
AC:
160
AN:
151178
Hom.:
0
Cov.:
32
AF XY:
0.000852
AC XY:
63
AN XY:
73904
show subpopulations
African (AFR)
AF:
0.00382
AC:
158
AN:
41318
American (AMR)
AF:
0.00
AC:
0
AN:
15164
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4912
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4622
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10568
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
67812
Other (OTH)
AF:
0.000949
AC:
2
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.517
Heterozygous variant carriers
0
7
15
22
30
37
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000270
Hom.:
1081
ExAC
AF:
0.000395
AC:
48
EpiCase
AF:
0.00
EpiControl
AF:
0.0000593

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Jun 01, 2016
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

BAAT-related disorder Benign:1
Dec 09, 2021
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

not provided Benign:1
Sep 24, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.075
BayesDel_addAF
Benign
-0.61
T
BayesDel_noAF
Benign
-0.65
CADD
Benign
3.6
DANN
Uncertain
0.98
DEOGEN2
Benign
0.032
T;T
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.017
N
M_CAP
Benign
0.0098
T
MetaRNN
Benign
0.0038
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.2
L;L
PhyloP100
-1.3
PrimateAI
Benign
0.19
T
PROVEAN
Benign
-1.0
N;N
REVEL
Benign
0.049
Sift
Uncertain
0.012
D;D
Sift4G
Uncertain
0.024
D;D
Polyphen
0.19
B;B
Vest4
0.18
MVP
0.38
MPC
0.074
ClinPred
0.016
T
GERP RS
-3.1
Varity_R
0.055
gMVP
0.21
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41281027; hg19: chr9-104130469; API